Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1Phase 2 1

Status

Completed 7Recruiting 5Withdrawn 2Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 5Myeloid 2Lymphoid 1Breast 1

Conditions

Leukemia, Myeloid, Acute 3Myelodysplastic Syndromes 2Hematologic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic-Myeloproliferative Diseases 1Mycoses 1Mucormycosis 1Genetic Predisposition to Disease 1Candidiasis 1Aspergillosis 1

Interventions

venetoclax 190Cyclophosphamide 123Azacitidine 112Cytarabine 108fludarabine 91Specimen Handling 74Biopsy 53Daunorubicin 42Methotrexate 41Dexamethasone 38Rituximab 34blinatumomab 32Vincristine 32Decitabine 31fludarabine phosphate 30Injections 28Granulocyte Colony-Stimulating Factor 28Whole-Body Irradiation 26Magnetic Resonance Spectroscopy 26obinutuzumab 25Idarubicin 25acalabrutinib 23Prednisone 23Mycophenolic Acid 23Melphalan 21Busulfan 21gilteritinib 19Mercaptopurine 19Doxorubicin 19ibrutinib 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × posaconazole × Other hematologic neoplasm × Clear all
NCT07155226 2026-05-19

MOMENTUM

AstraZeneca

Phase 1/2 Recruiting
84 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04771130 2026-04-23

A Study of BGB-11417 in Participants With Myeloid Malignancies

BeOne Medicines

Phase 1/2 Recruiting
260 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

NCT06541067 2026-01-26

POSALLO

Nantes University Hospital

Phase 2 Recruiting
30 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT03828773 2025-12-09

PTX3AML

Centre Hospitalier Universitaire Vaudois

Phase NA Recruiting
410 enrolled
Other hematologic neoplasm

Aspergillosis, Candidiasis, Mycoses, Leukemia, Myeloid, Acute, Genetic Predisposition to Disease

NCT07185503 2025-09-22

Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety

Institute of Hematology & Blood Diseases Hospital, China

Recruiting
60 enrolled
Other hematologic neoplasm

Mucormycosis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡